Maat Pharma (XPAR:MAAT) Short-Term Capital Lease Obligation : €0.97 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Short-Term Capital Lease Obligation?

Maat Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.97 Mil.

Maat Pharma's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (€0.91 Mil) to Jun. 2024 (€0.91 Mil) and increased from Jun. 2024 (€0.91 Mil) to Dec. 2024 (€0.97 Mil).

Maat Pharma's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (€0.20 Mil) to Dec. 2023 (€0.91 Mil) and increased from Dec. 2023 (€0.91 Mil) to Dec. 2024 (€0.97 Mil).

Maat Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Maat Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Short-Term Capital Lease Obligation Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.08

0.20

0.91

0.97

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							0.20	0.20	0.91	0.91	0.97

Maat Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Maat Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines